OCM
ADMA icon

Ovata Capital Management’s ADMA Biologics ADMA Stock Holding History

Ovata Capital Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,000
Closed -$5K – 54
2022
Q1 		$5K Buy
+3,000
New +$4.68K ﹤0.01% 138

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Ovata Capital Management's ADMA Position: Q2 2022 in Review

Ovata Capital Management sold out of ADMA Biologics (ADMA) in Q2 2022, closing a stake of 3,000 shares — an estimated $5K sold.

Ovata Capital Management first reported a position in ADMA in Q1 2022 and held it in 1 quarter. The position peaked at $5K in Q1 2022. 113 funds tracked by Wall St. Rank hold ADMA as of Q2 2022.

  • Ovata Capital Management reported no remaining ADMA Biologics position as of Q2 2022 after selling out during the quarter.
  • Ovata Capital Management sold 3,000 ADMA Biologics shares in Q2 2022, an estimated $5K.
  • Ovata Capital Management first reported a position in ADMA Biologics in Q1 2022 and held it in 1 quarter.
  • Ovata Capital Management's ADMA Biologics position peaked at $5K in Q1 2022.
  • 113 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2022.

Based on Ovata Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.